Literature DB >> 29354168

Glomus tumor as a cause of oncogenic osteomalacia.

Mehdi Dehghani1, Mohammad Hossien Dabbaghmanesh2, Abolfazele Khalafi-Nezhad1, Nader Riazmontazer3, Amireza Dehghanian3, Reza Vojdani1, Mohammadreza Sasani4.   

Abstract

Many tumors that occasionally are benign in origin causes hypophosphatemic osteomalacia. Here we present a case of glomus tumor in a 59-year-old man with oncogenic osteomalacia. Diagnosis was made after observation of abnormal increase activity in octreotide scan. The magnetic resonance imaging showed a round lesion in left ankle joint. Surgical excision of tumor was curative and all symptoms and intractable hypophosphatemia improved after few weeks.

Entities:  

Keywords:  acquired hypophosphatemic rickets; glomus tumor; hypophosphatemia; oncogenic osteomalacia; tumor-induced osteomalacia

Year:  2017        PMID: 29354168      PMCID: PMC5762230          DOI: 10.11138/ccmbm/2017.14.3.359

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  22 in total

1.  Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management.

Authors:  G P Clunie; P E Fox; T C Stamp
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

Review 2.  Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.

Authors:  Yan Jiang; Wei-bo Xia; Xiao-ping Xing; Barbara C Silva; Mei Li; Ou Wang; Hua-bing Zhang; Fang Li; Hong-li Jing; Ding-romg Zhong; Jin Jin; Peng Gao; Lian Zhou; Fang Qi; Wei Yu; John P Bilezikian; Xun-wu Meng
Journal:  J Bone Miner Res       Date:  2012-09       Impact factor: 6.741

Review 3.  Tumor-Induced Osteomalacia: an Up-to-Date Review.

Authors:  Anke H Hautmann; Matthias G Hautmann; Oliver Kölbl; Wolfgang Herr; Martin Fleck
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 4.  [Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia].

Authors:  Yuka Kinoshita; Seiji Fukumoto
Journal:  Clin Calcium       Date:  2014-08

Review 5.  The use of gallium-68 labeled somatostatin receptors in PET/CT imaging.

Authors:  Valentina Ambrosini; Cristina Nanni; Stefano Fanti
Journal:  PET Clin       Date:  2014-04-26

6.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

7.  Tumor-induced osteomalacia: a single center experience.

Authors:  Varsha S Jagtap; Vijaya Sarathi; Anurag R Lila; Gaurav Malhotra; Shilpa S Sankhe; Tushar Bandgar; Padmavathy Menon; Nalini S Shah
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

8.  Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.

Authors:  Michael S Hofman; W F Eddie Lau; Rodney J Hicks
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

9.  Malignant Gastric Glomus Tumor: A Case Report and Literature Review of a Rare Entity.

Authors:  Shaesta Zaidi; Maha Arafah
Journal:  Oman Med J       Date:  2016-01

10.  Extracutaneous glomus tumour of the trachea.

Authors:  Daniel Brzeziński; Mariusz Piotr Łochowski; Dorota Jesionek-Kupnicka; Józef Kozak
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-09-28
View more
  3 in total

1.  Unusual glomus tumor of the lower leg: A case report.

Authors:  Han-Yu Wang; Ping Duan; Hui Chen; Zhen-Yu Pan
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.534

2.  Glomus tumors associated with the bone and joints: a review of 91 cases.

Authors:  Yingjie Wang; Yongbo Xiang; Yanyan Bian; Bin Feng; Yong Liu; Xi Zhou; Lizhi Zhou; Xisheng Weng
Journal:  Ann Transl Med       Date:  2020-11

Review 3.  Glomus tumors around or in the knee: a case report and literature review.

Authors:  Yingjie Wang; Zehui Lv; Tian Li; Yanyan Bian; Bin Feng; Yong Liu; Xi Zhou; Xisheng Weng
Journal:  BMC Surg       Date:  2022-03-16       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.